Evidence for ACE2-utilizing coronaviruses (covs) related to severe acute respiratory syndrome cov in bats

Journal of Virology

Volumn 86, Issue 11, 2012, Pages 6350-6353

  Demogines, Ann ^a   Farzan, Michael ^b   Sawyer, Sara L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2 RECEPTOR; CELL SURFACE RECEPTOR; UNCLASSIFIED DRUG; VIRUS SPIKE PROTEIN; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; VIRUS RECEPTOR;

ANGIOTENSIN CONVERTING ENZYME 2 GENE; ARTICLE; BAT; EVOLUTIONARY RATE; GENETIC SELECTION; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR GENE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SPECIES COMPARISON; SPECIES DIFFERENCE; VIRUS ENTRY; VIRUS RECOMBINATION; VIRUS TRANSMISSION; ZOONOSIS; ANIMAL; CHEMICAL STRUCTURE; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

CORONAVIRUS; SARS CORONAVIRUS;

ANIMALS; CHIROPTERA; HUMANS; MODELS, MOLECULAR; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, VIRUS; SARS VIRUS; SELECTION, GENETIC; VIRUS INTERNALIZATION;

EID: 84863599046     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00311-12     Document Type: Article

References (41)

1. Baranowski E, Ruiz-Jarabo CM, Domingo E. 2001. Evolution of cell recognition by viruses. Science 292:1102-1105.
2. Becker MM, et al. 2008. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl. Acad. Sci. U. S. A. 105:19944-19949.
3. Demogines A, Truong KA, Sawyer SL. 2012. Species-specific features of DARC, the primate receptor for Plasmodium vivax and Plasmodium knowlesi. Mol. Biol. Evol. 29:445-449.
4. Elde NC, Child SJ, Geballe AP, Malik HS. 2009. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457:485-489.
5. Graham RL, Baric RS. 2010. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 84: 3134-3146.
6. Guan Y, et al. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302:276-278.
7. Gupta RK, et al. 2009. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5:e1000443.
8. Hofmann H, et al. 2006. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J. Virol. 80:8639-8652.
9. Hofmann H, et al. 2005. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. U. S. A. 102:7988-7993.
10. Holmes EC, Rambaut A. 2004. Viral evolution and the emergence of SARS coronavirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359:1059-1065.
11. Hou Y, et al. 2010. Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. Arch. Virol. 155:1563-1569.
12. Kaelber JT, et al. Evolutionary reconstructions of the transferrin receptor of Caniforms supports canine parvovirus being a re-emerged and not a novel pathogen in dogs. PLoS Pathog., in press.
13. Kan B, et al. 2005. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J. Virol. 79:11892-11900.
14. Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ. 2000. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J. Virol. 74:1393-1406.
15. Lau SKP, et al. 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U. S. A. 102:14040-14045.
16. Li F. 2008. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J. Virol. 82:6984-6991.
17. Li F, Li W, Farzan M, Harrison S. 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309: 1864-1868.
18. Li W, et al. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science 310:676-679.
19. Li W, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
20. Li W, et al. 2006. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J. Virol. 80:4211-4219.
21. Li W, et al. 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24:1634-1643.
22. Lim ES, et al. 2012. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11:194-204.
23. Lim ES, Malik HS, Emerman M. 2010. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J. Virol. 84:7124-7134.
24. Meyerson NR, Sawyer SL. 2011. Two-stepping through time: mammals and viruses. Trends Microbiol. 19:286-294.
25. Parrish CR, et al. 2008. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72:457-470.
26. Qu X-X, et al. 2005. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J. Biol. Chem. 280:29588-29595.
27. Ren W, et al. 2008. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J. Virol. 82:1899-1907.
28. Rest JS, Mindell DP. 2003. SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting. Infect. Genet. Evol. 3:219-225.
29. Sawyer SL, Wu LI, Emerman M, Malik HS. 2005. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U. S. A. 102:2832-2837.
30. Sheahan T, et al. 2008. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J. Virol. 82:2274-2285.
31. Sheahan T, Rockx B, Donaldson E, Corti D, Baric R. 2008. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus. J. Virol. 82:8721-8732.
32. Shi Z, Hu Z. 2008. A review of studies on animal reservoirs of the SARS coronavirus. Virus Res. 133:74-87.
33. Stanhope MJ, Brown JR, Amrine-Madsen H. 2004. Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV. Infect. Genet. Evol. 4:15-19.
34. Stavrinides J, Guttman DS. 2004. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J. Virol. 78:76-82.
35. Stehle T, Casasnovas JM. 2009. Specificity switching in virus-receptor complexes. Curr. Opin. Struct. Biol. 19:181-188.
36. Towler P. 2004. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 279: 17996-18007.
37. Wu D, et al. 2005. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J. Virol. 79:2620-2625.
38. Wu K, et al. 2011. A virus-binding hot spot on human angiotensinconverting enzyme 2 is critical for binding of two different coronaviruses. J. Virol. 85:5331-5337.
39. Wu K, Li W, Peng G, Li F. 2009. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc. Natl. Acad. Sci. U. S. A. 106:19970-19974.
40. Yang Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.
41. Yang Z, Bielawski J. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15:496-503.